Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Operations

v3.5.0.2
Consolidated Statement of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Net revenue $ 96,324 $ 95,191 $ 300,696 $ 201,411
Cost of net revenue 40,820 44,141 121,109 101,748
Gross profit 55,504 51,050 179,587 99,663
Operating expenses:        
Research and development 25,921 23,491 73,710 62,765
Selling, general and administrative 17,619 25,457 47,734 60,021
IPR&D impairment losses 1,300 0 1,300 0
Restructuring charges 0 425 2,106 11,814
Total operating expenses 44,840 49,373 124,850 134,600
Income (loss) from operations 10,664 1,677 54,737 (34,937)
Interest income 89 47 426 168
Other income (expense), net 10 407 (64) 351
Income (loss) before income taxes 10,763 2,131 55,099 (34,418)
Provision for income taxes (income tax benefit) 1,084 549 2,155 (631)
Net income (loss) $ 9,679 $ 1,582 $ 52,944 $ (33,787)
Net income (loss) per share:        
Basic $ 0.15 $ 0.03 $ 0.83 $ (0.67)
Diluted $ 0.14 $ 0.03 $ 0.79 $ (0.67)
Shares used to compute net income (loss) per share:        
Basic 64,241 60,644 63,454 50,528
Diluted 67,832 63,209 67,354 50,528